In their study on RCC, Gordan and coworkers [16] proposed that HIF-1α specifically disrupts c-Myc:Max and c-Myc:SP-1 complexes, allowing more Mad:Max interaction and DNA binding. The gene discussed is HIF1A; the disease is renal cell carcinoma.